Archive: April 2013. TannerMedico announced that it would present Asonor at Expopharm in Düsseldorf on 18–21 September 2013, at Hall 17, Stand A29.
The invitation was addressed to existing and prospective international partners and German pharmacy professionals. The event details are retained as company history and do not describe a current exhibition.
A note on the original product claims
Earlier wording on this page linked snoring with a broad range of diseases and implied benefits beyond snoring relief. Those statements have been removed. An exhibition announcement is not evidence that a product prevents sleep apnea, cardiovascular disease or cancer.
Current product information
Read the official Asonor instructions for use and Quality & Regulatory information. For distribution enquiries or current availability, contact TannerMedico.
Editorial review: 2 October 2026. Published by TannerMedico A/S, the manufacturer of Asonor.

